Product Information
ATORVASTATIN 10 MG TABLET is a generic product labeled by Micro Labs Limited, priced at $0.0228 per EA under NDC 42571017290. Its NADAC has been published 334 times since May 13, 2020.
FDA first approved this application on Nov 7, 2019.
Strength
10 mg/1
Manufacturer
Micro Labs LimitedNDC
42571017290
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ATORVASTATIN CALCIUM TRIHYDRATEApproval Type
Generic (ANDA)
FDA Application
ANDA205945FDA Approved
11/7/2019
On Market Since
1/1/2020
Pharmacological Classes
Price Statistics
The NADAC for ATORVASTATIN 10 MG TABLET has been published 334 times since May 13, 2020, and over the history we have for it it has declined 62.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0228 per EA |
|---|---|
| All-time high | $0.0619 (Jun 10, 2020) |
| All-time low | $0.0224 (Nov 20, 2024) |
| 52-week high | $0.0258 |
| 52-week low | $0.0228 |
| Median price | $0.0315 |
| Average price | $0.0331 |
| Largest weekly change | -25.9% (Apr 17, 2024) |
| Weeks tracked | 334 |
| Tracking since | May 13, 2020 |
Generic Alternatives
The matcher finds 10 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Micro Labs Limited manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
ATORVASTATIN CALCIUM market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
HMG-CoA Reductase Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ATORVASTATIN 10 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ATORVASTATIN 10 MG TABLET, manufactured by Micro Labs Limited, is $0.0228 per EA (NDC 42571017290), effective Sep 30, 2026.
How has the price of ATORVASTATIN 10 MG TABLET changed over time?
Over the history we have for it, the NADAC for ATORVASTATIN 10 MG TABLET has declined 62.1%. It has been tracked across 334 weekly CMS publications since May 13, 2020.
What are the highest and lowest recorded NADAC prices for ATORVASTATIN 10 MG TABLET?
Since May 13, 2020, the NADAC for ATORVASTATIN 10 MG TABLET has ranged from a low of $0.0224 (Nov 20, 2024) to a high of $0.0619 (Jun 10, 2020), with a median of $0.0315 per EA.
Are there cheaper alternatives to ATORVASTATIN 10 MG TABLET?
10 manufacturers publish a NADAC-priced product with the same active ingredient and strength as ATORVASTATIN 10 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures ATORVASTATIN 10 MG TABLET?
ATORVASTATIN 10 MG TABLET (NDC 42571017290) is labeled by Micro Labs Limited, and CMS classifies it as a generic product.